Combination therapy can prolong life in severe heart disease

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is associated with a high risk of death. Until now, treatment has consisted of valve replacement, while the deposits in the heart muscle, known as amyloidosis, often remain untreated. Researchers have now demonstrated that combined treatment consisting of heart valve replacement and specific drug therapy offers a significant survival advantage for patients.

Aortic valve narrowing (aortic stenosis) with concomitant cardiac amyloidosis is a severe heart disease of old age that is associated with a high risk of death. Until now, treatment has consisted of valve replacement, while the deposits in the heart muscle, known as amyloidosis, often remain untreated. Researchers have now demonstrated that combined treatment consisting of heart valve replacement and specific drug therapy offers a significant survival advantage for patients.

Read more https://www.sciencedaily.com/releases/2025/06/250602155508.htm